{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:38:05Z","timestamp":1783337885839,"version":"3.54.6"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1124\/jpet.113.204644","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T04:18:33Z","timestamp":1371183513000},"page":"414-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Effect of the Mixed Phosphodiesterase 3\/4 Inhibitor RPL554 on Human Isolated Bronchial Smooth Muscle Tone"],"prefix":"10.1016","volume":"346","author":[{"given":"Luigino","family":"Calzetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive P.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rogliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Facciolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriella","family":"Matera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.113.204644_bib1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1476-5381.1996.tb16030.x","article-title":"The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-asthma drugs on inflammatory cell activation","volume":"119","author":"Banner","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.113.204644_bib2","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1476-5381.2009.00170.x","article-title":"Dual PDE3\/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease","volume":"157","author":"Banner","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.113.204644_bib3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrm911","article-title":"Cyclic nucleotide research\u2014still expanding after half a century","volume":"3","author":"Beavo","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/jpet.113.204644_bib4","first-page":"1","article-title":"Synergy, additivism and antagonism in immunosuppression. A critical review","volume":"28","author":"Berenbaum","year":"1977","journal-title":"Clin Exp Immunol"},{"key":"10.1124\/jpet.113.204644_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0031-6997(25)00026-2","article-title":"What is synergy?","volume":"41","author":"Berenbaum","year":"1989","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.113.204644_bib6","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.rmed.2010.05.017","article-title":"Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD","volume":"104","author":"Berton","year":"2010","journal-title":"Respir Med"},{"key":"10.1124\/jpet.113.204644_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bbrc.2006.08.180","article-title":"Profiling human phosphodiesterase genes and splice isoforms","volume":"350","author":"Bingham","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.113.204644_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0034-5687(01)00252-3","article-title":"High strength stimulation of the vagus nerve in awake humans: a lack of cardiorespiratory effects","volume":"127","author":"Binks","year":"2001","journal-title":"Respir Physiol"},{"key":"10.1124\/jpet.113.204644_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(80)90202-2","article-title":"Antagonism of an indirectly acting agonist: block by propranolol and sotalol of the action of tyramine on rat heart","volume":"65","author":"Black","year":"1980","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.113.204644_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.bjp.0701833","article-title":"Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4","volume":"124","author":"Blease","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.113.204644_bib11","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/sim.3005","article-title":"Quantifying synergism\/antagonism using nonlinear mixed-effects modeling: a simulation study","volume":"27","author":"Boik","year":"2008","journal-title":"Stat Med"},{"key":"10.1124\/jpet.113.204644_bib12","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jaci.2006.02.045","article-title":"Are phosphodiesterase 4 inhibitors just more theophylline?","volume":"117","author":"Boswell-Smith","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/jpet.113.204644_bib13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1124\/jpet.105.099192","volume":"318","author":"Boswell-Smith","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.204644_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.diagmicrobio.2006.01.024","article-title":"Mathematical formulation of additivity for antimicrobial agents","volume":"55","author":"Boucher","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1124\/jpet.113.204644_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(09)61255-1","article-title":"Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials","volume":"374","author":"Calverley","year":"2009","journal-title":"Lancet"},{"key":"10.1124\/jpet.113.204644_bib16","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1165\/rcmb.2011-0056OC","article-title":"Pharmacological characterization of adenosine receptors on isolated human bronchi","volume":"45","author":"Calzetta","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/jpet.113.204644_bib17","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1165\/rcmb.2010-0306OC","article-title":"Protein prenylation contributes to the effects of LPS on EFS-induced responses in human isolated bronchi","volume":"45","author":"Cazzola","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/jpet.113.204644_bib18","first-page":"A1497","article-title":"Safety and bronchodilator effects of nebulised RPL 554, a novel dual PDE3\/4 inhibitor in COPD (Abstract)","volume":"187","author":"Cazzola","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.113.204644_bib19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.rmed.2004.10.004","article-title":"Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients","volume":"99","author":"Cazzola","year":"2005","journal-title":"Respir Med"},{"key":"10.1124\/jpet.113.204644_bib20","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1183\/09031936.00213711","article-title":"Emerging anti-inflammatory strategies for COPD","volume":"40","author":"Cazzola","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.113.204644_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1124\/pr.111.004580","article-title":"Pharmacology and therapeutics of bronchodilators","volume":"64","author":"Cazzola","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.113.204644_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/pulp.1996.0012","article-title":"Isolated, electrically-stimulated airway preparations\u2014their use in determining beta-adrenoceptor agonist activity","volume":"9","author":"Coleman","year":"1996","journal-title":"Pulm Pharmacol"},{"key":"10.1124\/jpet.113.204644_bib23","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1074\/jbc.R200029200","article-title":"Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling","volume":"278","author":"Conti","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.113.204644_bib24","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1476-5381.1992.tb14451.x","article-title":"Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitors","volume":"106","author":"de Boer","year":"1992","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.113.204644_bib25","first-page":"A3875","article-title":"RPL554, a dual PDE3\/4 inhibitor, is well tolerated and maintains bronchodilator activity when administered by inhalation to mild-to-moderate allergic asthmatics on 6 consecutive days (Abstract)","volume":"187","author":"Franciosi","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.113.204644_bib26","first-page":"H655","article-title":"Contractile properties of isolated vascular smooth muscle after photoradiation","volume":"256","author":"Freas","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.113.204644_bib27","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/sj.bjp.0701688","article-title":"Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferation","volume":"123","author":"Gantner","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.113.204644_bib28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/pupt.1999.0220","article-title":"Characterization of the phosphodiesterase (PDE) pattern of in vitro-generated human dendritic cells (DC) and the influence of PDE inhibitors on DC function","volume":"12","author":"Gantner","year":"1999","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1124\/jpet.113.204644_bib29","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/j.1476-5381.1996.tb15629.x","article-title":"Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2","volume":"118","author":"Giembycz","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.113.204644_bib30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.tiv.2007.03.003","article-title":"A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model","volume":"21","author":"Goldoni","year":"2007","journal-title":"Toxicol In Vitro"},{"key":"10.1124\/jpet.113.204644_bib31","series-title":"Goodman & Gilman\u2019s Manual of Pharmacology and Therapeutics","author":"Goodman","year":"2008"},{"key":"10.1124\/jpet.113.204644_bib32","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1124\/jpet.104.067264","article-title":"Isobolographic analysis for combinations of a full and partial agonist: curved isoboles","volume":"310","author":"Grabovsky","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.204644_bib33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0031-6997(25)06847-4","article-title":"The search for synergy: a critical review from a response surface perspective","volume":"47","author":"Greco","year":"1995","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.113.204644_bib34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1094-5539(03)00090-7","article-title":"Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD)","volume":"16","author":"Grootendorst","year":"2003","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1124\/jpet.113.204644_bib35","first-page":"61","article-title":"Ethanol suppresses L-arginine-induced relaxation response of rat aorta stimulated with bacterial lipopolysaccharide","volume":"35","author":"Hatake","year":"2000","journal-title":"Nihon Arukoru Yakubutsu Igakkai Zasshi"},{"key":"10.1124\/jpet.113.204644_bib36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0022-3565(24)29537-9","article-title":"Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro","volume":"297","author":"Hatzelmann","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.204644_bib37","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1124\/jpet.111.186379","article-title":"Preclinical evaluation of an inhibitor of cytosolic phospholipase A2\u03b1 for the treatment of asthma","volume":"340","author":"Hewson","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.204644_bib38","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1124\/jpet.106.107375","article-title":"Determining the potency and molecular mechanism of action of insurmountable antagonists","volume":"319","author":"Kenakin","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.204644_bib39","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4097\/kjae.2010.58.5.421","article-title":"Drug interaction: focusing on response surface models","volume":"58","author":"Lee","year":"2010","journal-title":"Korean J Anesthesiol"},{"key":"10.1124\/jpet.113.204644_bib40","doi-asserted-by":"crossref","first-page":"35980","DOI":"10.1074\/jbc.M204832200","article-title":"Cyclic AMP-dependent transcriptional up-regulation of phosphodiesterase 4D5 in human airway smooth muscle cells. Identification and characterization of a novel PDE4D5 promoter","volume":"277","author":"Le Jeune","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.113.204644_bib41","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.pupt.2009.04.005","article-title":"Relaxant effect of brain natriuretic peptide in nonsensitized and passively sensitized isolated human bronchi","volume":"22","author":"Matera","year":"2009","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1124\/jpet.113.204644_bib42","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/j.1476-5381.2011.01339.x","article-title":"Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi","volume":"163","author":"Matera","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.113.204644_bib43","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pupt.2012.09.003","article-title":"Epithelial-smooth muscle cooperation is needed for brain natriuretic peptide-dependent bronchorelaxant activity","volume":"26","author":"Matera","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1124\/jpet.113.204644_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1517\/14728214.2012.660917","article-title":"Emerging drugs for chronic obstructive pulmonary disease","volume":"17","author":"Matera","year":"2012","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1124\/jpet.113.204644_bib45","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.tips.2011.04.003","article-title":"Novel bronchodilators for the treatment of chronic obstructive pulmonary disease","volume":"32","author":"Matera","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.113.204644_bib46","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1096\/fj.03-0274com","article-title":"PDE4D plays a critical role in the control of airway smooth muscle contraction","volume":"17","author":"M\u00e9hats","year":"2003","journal-title":"FASEB J"},{"key":"10.1124\/jpet.113.204644_bib47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1128\/AAC.47.1.106-117.2003","article-title":"In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates","volume":"47","author":"Meletiadis","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.113.204644_bib48","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1183\/09031936.02.00275702","article-title":"Relaxation of proximal and distal isolated human bronchi by halothane, isoflurane and desflurane","volume":"20","author":"Mercier","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.113.204644_bib49","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2222.2011.03715.x","article-title":"Oxidative stress-induced glucocorticoid resistance is prevented by dual PDE3\/PDE4 inhibition in human alveolar macrophages","volume":"41","author":"Milara","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1124\/jpet.113.204644_bib50","series-title":"Intuitive Biostatistics","author":"Motulsky","year":"1995"},{"key":"10.1124\/jpet.113.204644_bib51","series-title":"Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting","author":"Motulsky","year":"2004"},{"key":"10.1124\/jpet.113.204644_bib52","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2125.2003.01760.x","article-title":"Bronchodilator effects of intravenous olprinone, a phosphodiesterase 3 inhibitor, with and without aminophylline in asthmatic patients","volume":"55","author":"Myou","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.113.204644_bib53","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1164\/ajrccm.160.3.9812065","article-title":"Bronchodilator effect of inhaled olprinone, a phosphodiesterase 3 inhibitor, in asthmatic patients","volume":"160","author":"Myou","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.113.204644_bib54","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1111\/j.1476-5381.1996.tb15628.x","article-title":"Effects of RP 73401, a novel, potent and selective phosphodiesterase type 4 inhibitor, on contractility of human, isolated bronchial muscle","volume":"118","author":"Naline","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.113.204644_bib55","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1164\/ajrccm.158.supplement_2.13tac130","article-title":"Mechanisms of immune sensitization of human bronchus","volume":"158","author":"Rabe","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.113.204644_bib56","first-page":"L458","article-title":"Phosphodiesterase isozymes modulating inherent tone in human airways: identification and characterization","volume":"264","author":"Rabe","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.113.204644_bib57","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.pupt.2013.01.002","article-title":"The influence of propofol, remifentanil and lidocaine on the tone of human bronchial smooth muscle","volume":"26","author":"Rogliani","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1124\/jpet.113.204644_bib58","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/sj.bjp.0703725","article-title":"The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C(4)-induced contractions in passively sensitized human airways","volume":"131","author":"Schmidt","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.113.204644_bib59","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1183\/09031936.95.08071179","article-title":"PDE isoenzymes as targets for anti-asthma drugs","volume":"8","author":"Schudt","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.113.204644_bib60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0079-6603(00)66031-2","article-title":"Regulation and function of the cyclic nucleotide phosphodiesterase (PDE3) gene family","volume":"66","author":"Shakur","year":"2001","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"10.1124\/jpet.113.204644_bib61","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.4049\/jimmunol.0900826","volume":"183","author":"Singh","year":"2009","journal-title":"J Immunol"},{"key":"10.1124\/jpet.113.204644_bib62","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0024-3205(98)00015-0","article-title":"The effect duration of selective phosphodiesterase inhibitors in the guinea pig","volume":"62","author":"Spina","year":"1998","journal-title":"Life Sci"},{"key":"10.1124\/jpet.113.204644_bib63","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3565(24)29450-7","article-title":"Drug synergism: its detection and applications","volume":"298","author":"Tallarida","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.204644_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with isobolograms","volume":"319","author":"Tallarida","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.204644_bib65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pharmthera.2010.04.011","article-title":"The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations","volume":"127","author":"Tallarida","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.113.204644_bib66","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1476-5381.2010.00975.x","article-title":"Dual bronchodilatory and pulmonary anti-inflammatory activity of RO5024118, a novel agonist at vasoactive intestinal peptide VPAC2 receptors","volume":"161","author":"Tannu","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.113.204644_bib67","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1164\/ajrccm.157.2.9708012","article-title":"Phosphodiesterase isozymes: molecular targets for novel antiasthma agents","volume":"157","author":"Torphy","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.113.204644_bib68","unstructured":"Istituto Nazionale dei Tumori - Independent Ethics Committee (2010) From the biobank to the research biorepository: ethical and legal recommendations, Milan, Italy. http:\/\/www.progettorol.it\/doc\/OECI_BIOBANKS_Oct.2010.pdf"},{"key":"10.1124\/jpet.113.204644_bib69","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1164\/ajrccm.155.3.9117014","article-title":"Role of IgE in hyperresponsiveness induced by passive sensitization of human airways","volume":"155","author":"Watson","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.113.204644_bib70","first-page":"L694","article-title":"Phosphodiesterase expression in human epithelial cells","volume":"275","author":"Wright","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.113.204644_bib71","doi-asserted-by":"crossref","unstructured":"Yick CY, Zwinderman AH, Kunst PW, Gr\u00fcnberg K, Mauad T, Dijkhuis A, Bel EH, Baas F, Lutter R, Sterk PJ (2013) Transcriptome sequencing (RNA-Seq) of human endobronchial biopsies: asthma versus controls. Eur Respir J erj01154-2012, doi: 10.1183\/09031936.00115412.","DOI":"10.1183\/09031936.00115412"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652428736X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652428736X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.113.204644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:16:15Z","timestamp":1739996175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652428736X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S002235652428736X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.113.204644","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of the Mixed Phosphodiesterase 3\/4 Inhibitor RPL554 on Human Isolated Bronchial Smooth Muscle Tone","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.113.204644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}